SABRE hyperpolarized anticancer agents for use in 1 H MRI. (2022)
Attributed to:
A National Centre for Translational Hyperpolarised Magnetic Resonance
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/mrm.29166
PubMed Identifier: 35253267
Publication URI: http://europepmc.org/abstract/MED/35253267
Type: Journal Article/Review
Volume: 88
Parent Publication: Magnetic resonance in medicine
Issue: 1
ISSN: 0740-3194